Stem cell therapy for moderate dementia
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new treatment made from stem cells (called secretome) to see if it can help people with moderate dementia. It's for patients who are generally stable and have a caregiver to support them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older.
- You have been diagnosed with dementia by a doctor, and recent memory tests show moderate impairment (score between 10 and 20 on the MMSE).
- Your health is generally stable, with no life-threatening conditions or uncontrolled diseases.
- You have a caregiver or family member who can assist you during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a peptide called PMS-001 can help improve long-term memory in people with moderate to severe dementia. It is designed for adults aged 60–80 who have significant memory problems and want to explore a new potential treatment.
This is a study that enrolls people with mild Alzheimer’s-related memory problems or dementia to help build a research “neurobank.” It also involves memory testing and may include brain scans, with a stable caregiver to support follow-up.
This trial tests a new stem cell treatment (called RB-ADSCs) that is injected into the fluid around your brain. It aims to see if these cells can help slow down memory loss and thinking problems in people with mild to moderate Alzheimer's disease.
This Phase 1 study tests whether injecting your own (autologous) activated fat-derived stem cells into the brain is safe and potentially helpful for mild to moderate Alzheimer’s disease. The goal is to see how the treatment affects the brain and symptoms, using cells made from your own donated fat tissue.
This trial tests a stem cell treatment for people with early-stage Alzheimer's disease. It aims to see if the treatment can help slow memory loss or other symptoms. You must have a specific blood test showing inflammation in the body to qualify.
This study tests whether tiny particles called exosomes derived from neural stem cells can help slow memory loss and thinking problems in people with Alzheimer's disease that started before age 65. The treatment is given through the nose and aims to reduce harmful proteins in the brain.
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.